Search research articles
Contact Us
Filters
Showing results (21-30 of 78) with videos related to
Page
of 8
Sort By:
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
November 25, 2020
Association Between Operative Approach and Venous Thromboembolism Rate Following Hepatectomy: a Propensity-Matched Analysis
Jonathan J Hue, Erryk Katayama, Sarah C Markt, et al.
Plos One
|
February 16, 2018
Insurance status and cancer treatment mediate the association between race/ethnicity and cervical cancer survival
Sarah C Markt, Tianyu Tang, Angel M Cronin, et al.
Surgery
|
January 17, 2021
Facility volume-survival relationship in patients with early-stage pancreatic adenocarcinoma treated with neoadjuvant chemotherapy followed by pancreatoduodenectomy
Jonathan J Hue, Kavin Sugumar, Sarah C Markt, et al.
Sleep
|
June 30, 2015
Insufficient Sleep and Risk of Prostate Cancer in a Large Swedish Cohort
Sarah C Markt, Alessandra Grotta, Olof Nyren, et al.
Cancer Medicine
|
July 15, 2022
Sociodemographic and clinical factors associated with receipt of biomarker testing in patients with metastatic colorectal cancer
Sarah C Markt, Benjamin D Booker, Wyatt Bensken, et al.
Clinical Genitourinary Cancer
|
July 3, 2017
A Walking Intervention Among Men With Prostate Cancer: A Pilot Study
Claire H Pernar, Katja Fall, Jennifer R Rider, et al.
International Journal of Cancer
|
September 2, 2016
Snus use, smoking and survival among prostate cancer patients
Kathryn M Wilson, Sarah C Markt, Fang Fang, et al.
Urology Practice
|
April 27, 2023
Bladder and Kidney Cancer Diagnosis and Survival Increase With Medicare Eligibility at Age 65
Timothy D Shu, Megan C Prunty, Raymond Pominville, et al.
Journal of Pancreatic Cancer
|
May 3, 2021
Immunotherapy Is Associated with a Survival Benefit in Patients Receiving Chemotherapy for Metastatic Pancreatic Cancer
Jonathan J Hue, Katherine Bingmer, Kavin Sugumar, et al.
JAMA Internal Medicine
|
June 3, 2014
5α-Reductase inhibitors and risk of high-grade or lethal prostate cancer
Mark A Preston, Kathryn M Wilson, Sarah C Markt, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 78) with videos related to
Sort By:
Page
of 8
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
November 25, 2020
Association Between Operative Approach and Venous Thromboembolism Rate Following Hepatectomy: a Propensity-Matched Analysis
Jonathan J Hue, Erryk Katayama, Sarah C Markt, et al.
Plos One
|
February 16, 2018
Insurance status and cancer treatment mediate the association between race/ethnicity and cervical cancer survival
Sarah C Markt, Tianyu Tang, Angel M Cronin, et al.
Surgery
|
January 17, 2021
Facility volume-survival relationship in patients with early-stage pancreatic adenocarcinoma treated with neoadjuvant chemotherapy followed by pancreatoduodenectomy
Jonathan J Hue, Kavin Sugumar, Sarah C Markt, et al.
Sleep
|
June 30, 2015
Insufficient Sleep and Risk of Prostate Cancer in a Large Swedish Cohort
Sarah C Markt, Alessandra Grotta, Olof Nyren, et al.
Cancer Medicine
|
July 15, 2022
Sociodemographic and clinical factors associated with receipt of biomarker testing in patients with metastatic colorectal cancer
Sarah C Markt, Benjamin D Booker, Wyatt Bensken, et al.
Clinical Genitourinary Cancer
|
July 3, 2017
A Walking Intervention Among Men With Prostate Cancer: A Pilot Study
Claire H Pernar, Katja Fall, Jennifer R Rider, et al.
International Journal of Cancer
|
September 2, 2016
Snus use, smoking and survival among prostate cancer patients
Kathryn M Wilson, Sarah C Markt, Fang Fang, et al.
Urology Practice
|
April 27, 2023
Bladder and Kidney Cancer Diagnosis and Survival Increase With Medicare Eligibility at Age 65
Timothy D Shu, Megan C Prunty, Raymond Pominville, et al.
Journal of Pancreatic Cancer
|
May 3, 2021
Immunotherapy Is Associated with a Survival Benefit in Patients Receiving Chemotherapy for Metastatic Pancreatic Cancer
Jonathan J Hue, Katherine Bingmer, Kavin Sugumar, et al.
JAMA Internal Medicine
|
June 3, 2014
5α-Reductase inhibitors and risk of high-grade or lethal prostate cancer
Mark A Preston, Kathryn M Wilson, Sarah C Markt, et al.
Page
of 8